Cosmos Health Inc. (NASDAQ:COSM) Short Interest Up 53.5% in December

Cosmos Health Inc. (NASDAQ:COSM) was the target of a large growth in short interest in the month of December. As of December 31st, there was short interest totalling 537,800 shares, a growth of 53.5% from the December 15th total of 350,300 shares. Currently, 2.9% of the company’s shares are sold short. Based on an average trading volume of 219,100 shares, the short-interest ratio is currently 2.5 days.

Cosmos Health Trading Up 2.7 %

NASDAQ:COSM traded up $0.02 on Friday, reaching $0.86. The company’s stock had a trading volume of 452,441 shares, compared to its average volume of 464,086. Cosmos Health has a 1-year low of $0.47 and a 1-year high of $1.58. The business’s 50-day moving average price is $0.71 and its two-hundred day moving average price is $0.91. The firm has a market cap of $19.94 million, a PE ratio of -0.35 and a beta of 5.57. The company has a debt-to-equity ratio of 0.08, a quick ratio of 1.24 and a current ratio of 1.44.

Insider Activity at Cosmos Health

In other news, CEO Grigorios Siokas purchased 257,334 shares of the firm’s stock in a transaction dated Friday, December 20th. The stock was bought at an average price of $0.58 per share, with a total value of $149,253.72. Following the acquisition, the chief executive officer now directly owns 3,774,314 shares of the company’s stock, valued at approximately $2,189,102.12. This represents a 7.32 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CFO Georgios Terzis acquired 85,778 shares of the stock in a transaction that occurred on Friday, December 20th. The stock was purchased at an average price of $0.58 per share, with a total value of $49,751.24. Following the transaction, the chief financial officer now owns 727,263 shares in the company, valued at $421,812.54. This represents a 13.37 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders have bought 569,278 shares of company stock worth $348,841 in the last ninety days. Company insiders own 15.61% of the company’s stock.

About Cosmos Health

Cosmos Health Inc manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names.